CorMedix Inc.
For the period ended Aug 13, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 13, 2026 · Filed Aug 13, 2026
CRMD$5.32+1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (In Thousands, Except Per Share Data)
(In Thousands, Except Per Share Data)
| For the Three Months EndedJune 30, | For the Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue and Grant Income: | ||||
| Product sales, net | $94,341 | $39,736 | $216,257 | $78,818 |
| Contract revenue | 4,966 | - | 8,048 | - |
| Grant income | 2,624 | - | 5,053 | - |
| Total Revenue and Grant Income | $101,931 | $39,736 | $229,358 | $78,818 |
| Cost of sales (exclusive of amortization of intangibles) | 14,505 | 1,810 | 26,510 | 3,355 |
| Amortization of intangibles | 10,300 | 52 | 20,600 | 104 |
| Gross profit | $77,126 | $37,874 | $182,248 | $75,359 |
| Operating Expenses: | ||||
| Research and development | $6,684 | $2,442 | $13,896 | $5,635 |
| Selling and marketing | 12,447 | 6,384 | 24,979 | 10,858 |
| General and administrative | 15,085 | 9,504 | 36,805 | 19,197 |
| Total Operating Expenses | $34,216 | $18,330 | $75,680 | $35,690 |
| Income From Operations | $42,910 | $19,544 | $106,568 | $39,669 |
| Other (Expense) Income: | ||||
| Unrealized gain (loss) on marketable equity security | 2,546 | - | (1,000) | - |
| Change in contingent consideration | (6,652) | - | (10,851) | - |
| Other non-operating (expense) income, net | (71) | 806 | (339) | 1,325 |
| Total Other (Expense) Income | (4,177) | 806 | (12,190) | 1,325 |
| Income before income taxes | 38,733 | 20,350 | 94,378 | 40,994 |
| Tax expense | 12,745 | 522 | 29,789 | 522 |
| Net Income | $25,988 | $19,828 | $64,589 | $40,472 |
| Net Income Per Common Share – Basic | $0.33 | $0.29 | $0.81 | $0.60 |
| Net Income Per Common Share - Diluted | $0.29 | $0.28 | $0.72 | $0.58 |
| Weighted Average Common Shares Outstanding – Basic | 78,444 | 67,928 | 78,949 | 66,593 |
| Weighted Average Common Shares Outstanding – Diluted | 92,479 | 71,919 | 92,543 | 70,354 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.